Singapore: Bayer HealthCare and its development partner Janssen Pharmaceuticals have initiated the CALLISTO Clinical Res...
Singapore: ASLAN Pharmaceuticals has inked a memorandum of understanding with Singapore's National Cancer Center (NCCS) ...
Singapore: While the treatment pipeline for pancreatic cancer shows a high level of innovation, with 52 percent of produ...
Singapore: US Food and Drug Administration has approved Varubi (rolapitant), marketed by US based, to prevent delayed ph...
Singapore: Bristol-Myers Squibb has elected Dr Thomas J Lynch to the board, effective January 1, 2014. Dr Lynch will ser...
Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on...
Singapore: Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based China...
Singapore: Eisai has revealed therapeutic effects of lenvatinib (generic name- VEGF receptor tyrosine kinase inhibitor a...
The product is ready for Day 1 launch, said Strides in a press release. Dutasteride is used to treat benign prostatic h...
Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...
Singapore: Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline...
Singapore: Taiwan's PharmaEngine has filed a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA...
Singapore: AOP Orphan, a pharmaceutical company in the field of rare diseases, has launched world's first drug approved ...
Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...
Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization co...
Singapore: 3SBio, China-based biotechnology company focused on researching, developing, manufacturing and marketing biop...
Singapore: US based Roivant Neurosciences, a biopharmaceutical company engaged in the development and commercialization ...
Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of ...
Bangalore: AstraZeneca and Cellworks have announced a collaboration, to speed the design of novel combination therapies ...
Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repur...
Singapore: Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cance...
‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formotero...
Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza s...
Singapore: Merck's grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis...
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...
Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its nove...
US-based Sprout Pharmaceuticals gained USFDA's approval for Addyi, whose chemical name is Flibanserin, created to enhanc...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
Singapore: Gilead Sciences has submitted a new drug application (NDA) to the US FDA for the approval of Idelalisib, an i...
Singapore: Taiwan based TWi Pharmaceutical's drug candidate AC-203 has received designation of rare disease drug by Taiw...
Singapore: A*Star's Genome Institute of Singapore (GIS) have successfully converted human embryonic stem cells (hESCs) c...
Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee ...
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...
Japan's leading pharmaceutical company Eisai Co. Ltd. has launched its in-house developed novel anticancer agent Lenvima...
Singapore: Isis Pharmaceuticals and AstraZeneca have made a strategic collaboration to discover and develop antisense th...
Singapore: Researchers have begun enrolling participants in to a multicenter international clinical trial to test whethe...
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...
Singapore: Janssen-Cilag International NV (Janssen) submitted a marketing authorization application to the European Medi...
Singapore: Thailand's former science and technology (S&T) minister, Professor Yongyuth Yuthavong, and his team have ...
Johnson & Johnson (J&J) has announced the start of a safety and immunogenicity clinical trial in Sierra Leone of...
Singapore: Singapore's ASLAN pharmaceuticals recently announced that the Food and Drug Administration (FDA) has granted ...
Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid le...
Singapore: Bayer's anticoagulant drug, Xarelto (rivaroxaban), has been approved by the China Food and Drug Administratio...
Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form...
Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in ...
Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone ...
Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combinat...
Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Can...
Tokyo: Japan's pharma giant Eisai Co Ltd announced that its European regional headquarters Eisai Europe Ltd has submitte...
Singapore: Baxter has acquired Oncaspar (pegaspargase) product portfolio, a first-line biologic used as part of a multi-...
Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients wi...
Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...
Mumbai: Lupin is setting up a R&D center in the US, and has hired the R&D head of Teva Pharmaceuticals and other...
Singapore: Janssen Pharmaceutical has terminated the research and development alliance with China based Hutchison Mediph...
In 2005, Novartis, a leading healthcare solution provider, decided to partner with The National Center For Genetic Engin...
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...
Singapore: Dengue, also known as break bone fever, is currently the most common vector-borne disease. The World Health ...
Singapore: Novartis received US FDA breakthrough therapy designation for BYM338 (bimagrumab) for sporadic inclusion body...
Singapore: Singapore based start-up firm, NMT Pharmaceuticals, has acquired an exclusive worldwide license right to furt...
Singapore: Boehringer Ingelheim and Circuit Therapeutics have formed a three-year collaboration to focus on investigatin...
Takeda Pharmaceutical Company Ltd and Paris-headquartered Enterome Bioscience SA have entered into a strategic drug disc...
Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...
Singapore: SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) u...
The Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended an approval for Madrid-based Pha...
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bristol-Myers Squibb's...
Singapore: Australia based Paradigm Biopharmaceuticals has been granted a patent by United States Patent and Trademark O...
Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to preve...
Singapore: China's leading pharmaceutical firm Yabao Pharmaceutical has inked a pact with the University of South Austra...
Singapore: Celgene International has received European Commission (EC) approval for VIDAZA (azacitidine for injection) f...
InvitroCue, the Australian company that works on advanced bio-analytics, has announced a key initiative on Malaria to id...
Singapore: Bionomics, Australia based biopharmaceutical company focused on the discovery and development of innovative t...
Singapore: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with...
Researchers affiliated with Kawasaki Innovation Gateway at SKYFRONT, Japan have discovered that incorporating gold nanop...
Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...
Singapore: Singapore based ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and ta...
Tokyo: Japanese pharmaceutical giant, Daiichi Sankyo Company Limited has announced that its wholly-owned subsidiary in ...
Roche has announced that the company has entered into an agreement to develop a companion diagnostic (CDx) test for dalc...
Singapore: AstraZeneca has bought bulk biologics manufacturing capacity from Amgen in US to expand its biologics manufac...
Singapore: United States Patent Office has issued official "Letters Patent" on a key patent in the PAT-LM1 family; US pa...
Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel t...
New York-based Progenics Pharmaceuticals' partner Fujifilm RI Pharma Co. Ltd. (Fuji) has dosed the first patient in its ...
Singapore: European firms, Crystal Bioscience and Boehringer Ingelheim, have entered into an agreement to collaborate on...
Japan' Daiichi Sankyo's domestic subsidiary, Daiichi Sankyo Espha Co Ltd. has obtained approval for partial changes conc...
Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...
Hyderabad: GVK Biosciences, Asia's leading drug discovery R&D organization, has received approvals from the Atomic ...
Singapore: Japan's Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement...
Singapore: Immunogen has inked a pact with Japanese drugmaker Takeda pharmaceuticals that gives Takeda exclusive rights ...
Singapore: The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being...
Singapore: On World Malaria Day, April 25, the WHO recognized significant accomplishments made in preventing and control...
Singapore: Roche reported that an independent data monitoring committee has obtained positive results from the phase III...
Singapore: The High Energy Accelerator Research Organization (KEK) and Japan-based Astellas Pharma have concluded an agr...
Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...
Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...
Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east A...
Singapore: Non-Small Cell Lung Cancer (NSCLC) treatment pipeline has a diverse selection of 122 first-in-class products ...
Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...
Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...
Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...
